Shapuaisi Obtains Drug Registration Certificate for Vitamin B12 Eye Drops

Jiemian··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Shapuaisi announced that the company has received the drug registration certificate for Vitamin B12 Eye Drops issued by the National Medical Products Administration. The specification is 0.02% (5ml:1mg), the registration classification is chemical drug category 4, and it is indicated for relieving symptoms of accommodative asthenopia. The company's cumulative R&D investment for this drug is approximately 4.1913 million yuan.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews